书目名称 | Competition Law and Policy in the Japanese Pharmaceutical Sector |
编辑 | Akira Negishi,Masako Wakui,Naoko Mariyama |
视频video | http://file.papertrans.cn/232/231141/231141.mp4 |
概述 | Provides a comprehensive guide to the Japanese pharmaceutical industry, focusing on competition law and policy.Examines the Japanese pharmaceutical sector, including competition, intellectual property |
丛书名称 | Kobe University Monograph Series in Social Science Research |
图书封面 |  |
描述 | .This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. ..Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States...Japan is one of the biggest pharmaceutical markets in |
出版日期 | Book 2022 |
关键词 | Antitrust law; Competition law; Pharmaceutical regulations; Antimonopoly; Intellectual property; Patent; M |
版次 | 1 |
doi | https://doi.org/10.1007/978-981-16-7814-1 |
isbn_softcover | 978-981-16-7816-5 |
isbn_ebook | 978-981-16-7814-1Series ISSN 2524-504X Series E-ISSN 2524-5058 |
issn_series | 2524-504X |
copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor |